Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 38.77%-8.64M | 64.07%-1.12M | 11.87%-2.57M | 30.78%-2.22M | 43.89%-2.73M | -37.53%-14.12M | -50.17%-3.13M | -18.63%-2.92M | -25.89%-3.2M | -53.18%-4.87M |
Net income from continuing operations | -33.48%-11.02M | 26.97%-1.7M | -95.58%-6.24M | 10.22%-2.2M | -202.39%-886K | 31.40%-8.26M | 41.36%-2.32M | -17.11%-3.19M | 2.27%-2.46M | 89.70%-293K |
Operating gains losses | 38.56%-3.46M | 98.39%-6K | 60.87%-153K | 52.33%-460K | 27.19%-2.84M | -615.29%-5.63M | -128.71%-373K | -574.14%-391K | -793.52%-965K | -9,407.32%-3.9M |
Depreciation and amortization | -16.48%1.38M | -49.78%225K | -28.29%332K | -0.25%407K | 24.26%420K | 72.07%1.66M | 59.43%448K | 65.36%463K | 100.99%408K | 69.85%338K |
Other non cash items | 17.73%-515K | -43.37%-119K | 40.32%-111K | 19.44%-145K | 20.90%-140K | -5.56%-626K | 53.63%-83K | -10.06%-186K | -46.34%-180K | -45.08%-177K |
Change In working capital | 118.44%286K | 140.84%332K | -427.99%-879K | 354.88%209K | 167.53%624K | -2,720.00%-1.55M | -312.27%-813K | 114.40%268K | 8.89%-82K | -95.35%-924K |
-Change in receivables | 216.67%490K | 136.32%158K | 5.48%77K | 13.92%90K | 220.44%165K | -1,515.38%-420K | -372.83%-435K | 87.18%73K | 154.84%79K | -3,325.00%-137K |
-Change in inventory | 114.85%72K | 36.94%-99K | 82.97%-31K | 161.33%157K | -59.09%45K | -246.43%-485K | -1,527.27%-157K | -774.07%-182K | -69.54%-256K | 507.41%110K |
-Change in prepaid assets | 282.58%482K | 830.30%241K | -375.24%-289K | 101.65%244K | 162.58%286K | -2,130.77%-264K | -109.19%-33K | -30.92%105K | 213.08%121K | -16.88%-457K |
-Change in payables and accrued expense | -6,200.00%-756K | 117.02%32K | -323.16%-636K | -4,566.67%-280K | 224.27%128K | -105.31%-12K | -193.53%-188K | 583.05%285K | -104.35%-6K | -90.74%-103K |
-Change in other current liabilities | 99.46%-2K | --0 | --0 | 90.00%-2K | --0 | -189.06%-370K | --0 | 61.76%-13K | -1,900.00%-20K | -11,333.33%-337K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 38.77%-8.64M | 64.07%-1.12M | 11.87%-2.57M | 30.78%-2.22M | 43.89%-2.73M | -37.53%-14.12M | -50.17%-3.13M | -18.63%-2.92M | -25.89%-3.2M | -53.18%-4.87M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 61.28%-194K | 116.13%10K | 70.48%-31K | 0 | 26.69%-173K | 54.50%-501K | 79.05%-62K | 79.41%-105K | -50.77%-98K | -2.61%-236K |
Net PPE purchase and sale | -33.73%-670K | -224.44%-146K | 74.59%-31K | -226.53%-320K | 26.69%-173K | 64.32%-501K | 84.80%-45K | 76.08%-122K | 73.37%-98K | -2.61%-236K |
Net other investing changes | --476K | --156K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 61.28%-194K | 116.13%10K | 70.48%-31K | --0 | 26.69%-173K | 54.50%-501K | 79.05%-62K | 79.41%-105K | -50.77%-98K | -2.61%-236K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -22.35%9.09M | -132.80%-102K | 3,347.73%2.86M | 1.01M | -53.62%5.33M | 251.05%11.71M | -91.91%311K | -88K | 0 | 11.49M |
Net issuance payments of debt | -206.14%-349K | -292.31%-102K | -20.45%-106K | ---99K | ---42K | 77.60%-114K | ---26K | ---88K | --0 | --0 |
Net common stock issuance | ---- | ---- | ---- | ---- | -58.62%2M | ---- | ---- | ---- | ---- | --4.84M |
Net preferred stock issuance | --0 | --0 | --0 | --0 | --0 | -100.05%-2K | --0 | --0 | --0 | ---2K |
Proceeds from stock option exercised by employees | 17.38%6.08M | 283.91%2.71M | 35.72%-3.11M | -35.70%3.11M | -49.37%3.37M | --5.18M | ---1.47M | ---4.84M | --4.84M | --6.65M |
Net other financing activities | -49.38%3.37M | ---- | ---- | ---- | ---- | --6.65M | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -22.35%9.09M | -132.80%-102K | 3,347.73%2.86M | --1.01M | -53.62%5.33M | 251.05%11.71M | -91.91%311K | ---88K | --0 | --11.49M |
Net cash flow | ||||||||||
Beginning cash position | -46.52%3.34M | -22.59%4.81M | -51.15%4.56M | -54.36%5.76M | -46.52%3.34M | -56.25%6.25M | 30.13%6.22M | 20.41%9.33M | 16.23%12.63M | -56.25%6.25M |
Current changes in cash | 108.88%258K | 57.76%-1.22M | 108.27%257K | 63.46%-1.21M | -62.04%2.42M | 63.81%-2.91M | -296.38%-2.88M | -4.75%-3.11M | -5.84%-3.3M | 287.13%6.38M |
End cash Position | 7.72%3.6M | 7.72%3.6M | -22.59%4.81M | -51.15%4.56M | -54.36%5.76M | -46.52%3.34M | -46.52%3.34M | 30.13%6.22M | 20.41%9.33M | 16.23%12.63M |
Free cash flow | 36.28%-9.33M | 60.34%-1.27M | 15.04%-2.58M | 21.95%-2.57M | 43.08%-2.91M | -25.51%-14.65M | -34.59%-3.2M | -2.32%-3.04M | -13.33%-3.3M | -49.77%-5.11M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |